MDAI
Spectral AI, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.53
+2.00%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.51
From 52W high−42.91%
Volume103117.00
Market cap$49.24M
P/E (TTM)—
P/S (TTM)3.2x
Div yield—
Key dataNov 4, 2026
Open
$1.51
From 52W high
−42.91%
Volume
103117.00
Market cap
$49.24M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−6.3x
P/E (TTM)
—
RSI (14)
48.1
MomentumView details →
1D Return
+2.00%
YTD Return
+8.45%
SummaryUpdated Jun 1, 2026
Spectral AI, Inc. (NASDAQ:MDAI) is a Dallas-based artificial intelligence company founded to revolutionize medical diagnostics in wound care. The company went public in April 2021 and has since focused on developing AI-powered diagnostic tools that help healthcare providers make faster and more accurate treatment decisions for patients with burns and diabetic foot ulcers. Spectral AI's flagship product, the DeepView system, represents a significant advancement in wound assessment technology, offering objective analysis capabilities that often surpass traditional clinical judgment.
Similar companies
Latest newsMore news →
Spectral AI announced that it will report third-quarter 2026 financial results and host a conference call on November 10, 2026.7d agoSpectral AI submitted a New Technology Add-On Payment application to the Centers for Medicare & Medicaid Services (US) for its DeepView System through the alternative pathway.29d agoSpectral AI completed the first Site Initiation Visit for a clinical study supporting label expansion of its FDA-cleared DeepView System for Burn Indication to include burns of the head, hands, and feet, conducted at Pinderfields Hospital in Wakefield, UK.34d ago